Press Releases Year All20242023202220212020201920182017 May 20, 2024 Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates May 16, 2024 Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel Apr 01, 2024 Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream Mar 13, 2024 Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
Year All20242023202220212020201920182017 May 20, 2024 Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates May 16, 2024 Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel Apr 01, 2024 Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream Mar 13, 2024 Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
May 16, 2024 Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
Apr 01, 2024 Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream